In The States – Page 11 – Weekly news about states

Kentucky

The Department for Medicaid Services (DMS) and MedImpact issued a bulletin to pharmacies promoting the administration of Human Papillomavirus (HPV) vaccines at pharmacies. Through December 1, 2024, pharmacies will receive a point-of-sale message when billing claims for Medicaid patients that DMS identified as HPV vaccine naive. Pharmacies may bill Medicaid for the product, the administration fee and counseling. NACDS serves on Medicaid’s Pharmacy Technical Advisory Committee (PTAC) that worked with DMS and the health plans to develop and advance the program. Fee-for-service and MedImpact contact information as well as the protocol have been provided to pharmacies.

Also in Kentucky, Medicaid and MedImpact issued bulletins related to MAC appeals and a reminder to pharmacies of their auto refill prohibition policy.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Michael Silber2024-10-24T14:06:00-04:00October 24, 2024|Kentucky|

Louisiana

The Department of Health (LDH) Bureau of Health Services Financing issued a notice informing Medicaid Pharmacy providers of the upcoming beneficiary third party liability (TPL) data migration that will begin on November 4, 2024. The TPL migration applies to pharmacy claims submitted to Gainwell for Fee for Service (FFS) and to Prime Therapeutics for MCOs (Aetna, AmeriHealth Caritas, Healthy Blue, Humana Healthy Horizons, Louisiana Healthcare Connections, and UnitedHealthcare).

Also in Louisiana, LDH issued an Informational Bulletin 24-37 updating the immunization fee schedule for 2024-2025.

Finally in Louisiana, on October 1, legislation signed into law by Gov. Jeff Landry (R) made Louisiana the first state to classify mifepristone and misoprostol, two abortion-inducing drugs, as controlled dangerous substances. While the drugs are still available with a prescription, they are now classified in the same category as some opioids.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Michael Silber2024-10-24T14:05:18-04:00October 24, 2024|Louisiana|

Maryland

COMAR 10.34.42 Pharmacist Prescribing of a Nicotine Replacement Therapy went into effect on October 14. This service is covered by Medicaid for enrolled pharmacies/pharmacists. These regulations are the result of the enactment of SB 62 of 2023 and payment for pharmacy services (Medicaid and commercial plans) as required by HB 1151 of 2023.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Michael Silber2024-10-24T14:04:44-04:00October 24, 2024|Maryland|

Massachusetts

The Board of Pharmacy issued the following two updates:

Policy 2024-02: Implantable Infusion Pumps – Outlines requirements for extended infusion times of compounded sterile preparations via implanted pumps.
247 CMR 13.00: Nuclear Pharmacy Licensure Requirements and Professional Practice Standards – The most significant change was to remove the requirement for the separate nuclear pharmacist license and defer nuclear pharmacist qualifications to the nuclear regulations at 105 CMR 120.526: Training for an Authorized Nuclear Pharmacist.

Also in Massachusetts, MassHealth released the latest Pharmacy Facts that includes a COVID-19 Vaccination Reimbursement Update.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

Michael Silber2024-10-24T14:04:09-04:00October 24, 2024|Massachusetts|

Michigan

The Board of Pharmacy posted the Pharmacy Rules Committee Workgroup Agenda for November 4.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Michael Silber2024-10-24T14:03:27-04:00October 24, 2024|Michigan|

Minnesota

NACDS reminds members that the new Medicaid Management Information System (MMIS) for pharmacy claims is scheduled to be implemented on November 4. For more information, see the Medical Assistance Portal.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Michael Silber2024-10-24T14:02:41-04:00October 24, 2024|Minnesota|

Missouri

Due to numerous questions on the drug shortages caused by the recent hurricanes, the Board of Pharmacy issued guidance to assist licensees.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Michael Silber2024-10-24T14:01:48-04:00October 24, 2024|Missouri|

Montana

Effective December 1, the Montana Pharmacy Association announced several changes: Stuart Doggett, Executive Director, will semi-retire; Deedee Grubs will begin as the association’s Executive Director; and Tony King, PharmD, MBA will serve as its lobbyist for the 2025 Montana Legislative session. Dr. King is currently the Retail Pharmacy Strategy Coordinator at St. Peter’s Health in Helena.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Michael Silber2024-10-24T14:00:54-04:00October 24, 2024|Montana|

Nebraska

The Department of Health and Human Services posted the Excel file of the fee schedule for Injectables October 1, 2024 and published 471-000-540 Nebraska Medicaid Practitioner Fee Schedule for Injectionables.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Michael Silber2024-10-24T14:00:18-04:00October 24, 2024|Nebraska|